Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 1999 Jun;49(443):455–458.

Postal urine specimens: are they a feasible method for genital chlamydial infection screening?

J Macleod 1, R Rowsell 1, P Horner 1, T Crowley 1, E O Caul 1, N Low 1, G D Smith 1
PMCID: PMC1313443  PMID: 10562745

Abstract

BACKGROUND: A United Kingdom (UK) screening programme for Chlamydia trachomatis has recently been announced. Pilot projects involving the opportunistic testing of women attending health facilities are due to commence in several sites. There is a danger that this approach will fail to obtain adequate population coverage. The alternative--true systematic population screening--is generally assumed to be unfeasible. Studies in Denmark using postal urine specimens have challenged this assumption. No such studies have been reported from the UK. AIM: To assess the potential of urine specimens sent by post as the basis for a UK population screening strategy for genital chlamydial infection. METHOD: Two hundred patients (100 men, 100 women) aged 18 to 45 years were randomly sampled from the list of one urban group practice. Subjects were mailed an explanatory letter, a urine sample container, a sexual lifestyle questionnaire, and a prepaid return envelope. Non-responders were contacted by telephone; persistent non-responders were visited at home. Samples were tested for Chlamydia by DNA amplification and enzyme immunoassay. RESULTS: Sixty-four (32%) subjects were no longer living at their GP registered address. Of the remaining 136, 126 (93%) responded to the survey and 113 (83%) accepted the request for a urine sample and completed a questionnaire. Acceptance rates were similar for men and women and across age groups. Four samples (3%) were Chlamydia positive. CONCLUSION: Home mailed urine specimen collection in conjunction with a self-completed postal questionnaire is feasible. This could provide a viable basis both for determining population Chlamydia prevalence and for a UK Chlamydia population screening strategy. Overall cost effectiveness of such a strategy will depend on the cost of the test used. Comparative performance characteristics of the different currently available tests in this setting have yet to be fully determined.

Full Text

The Full Text of this article is available as a PDF (50.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abter E. I., Mahmud M. A. Screening for chlamydia to prevent pelvic inflammatory disease. N Engl J Med. 1996 Nov 14;335(20):1531–1533. doi: 10.1056/NEJM199611143352012. [DOI] [PubMed] [Google Scholar]
  2. Bower H. Britain launches pilot screening programme for chlamydia. BMJ. 1998 May 16;316(7143):1479–1479. doi: 10.1136/bmj.316.7143.1477e. [DOI] [PubMed] [Google Scholar]
  3. Bowling A., Jacobson B. Screening: the inadequacy of population registers. BMJ. 1989 Mar 4;298(6673):545–546. doi: 10.1136/bmj.298.6673.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dickson N., Paul C., Herbison P. Where young people with multiple sexual partners seek medical care: implications for screening for chlamydial infection. Sex Transm Infect. 1998 Dec;74(6):445–447. doi: 10.1136/sti.74.6.445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Egger M., Low N., Smith G. D., Lindblom B., Herrmann B. Screening for chlamydial infections and the risk of ectopic pregnancy in a county in Sweden: ecological analysis. BMJ. 1998 Jun 13;316(7147):1776–1780. doi: 10.1136/bmj.316.7147.1776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grun L., Tassano-Smith J., Carder C., Johnson A. M., Robinson A., Murray E., Stephenson J., Haines A., Copas A., Ridgway G. Comparison of two methods of screening for genital chlamydial infection in women attending in general practice: cross sectional survey. BMJ. 1997 Jul 26;315(7102):226–230. doi: 10.1136/bmj.315.7102.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hadgu A. The discrepancy in discrepant analysis. Lancet. 1996 Aug 31;348(9027):592–593. doi: 10.1016/S0140-6736(96)05122-7. [DOI] [PubMed] [Google Scholar]
  8. Horner P. J., Crowley T., Leece J., Hughes A., Smith G. D., Caul E. O. Chlamydia trachomatis detection and the menstrual cycle. Lancet. 1998 Jan 31;351(9099):341–342. doi: 10.1016/S0140-6736(05)78335-5. [DOI] [PubMed] [Google Scholar]
  9. Johnson A. M., Grun L., Haines A. Controlling genital chlamydial infection. BMJ. 1996 Nov 9;313(7066):1160–1161. doi: 10.1136/bmj.313.7066.1160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lee H. H., Chernesky M. A., Schachter J., Burczak J. D., Andrews W. W., Muldoon S., Leckie G., Stamm W. E. Diagnosis of Chlamydia trachomatis genitourinary infection in women by ligase chain reaction assay of urine. Lancet. 1995 Jan 28;345(8944):213–216. doi: 10.1016/s0140-6736(95)90221-x. [DOI] [PubMed] [Google Scholar]
  11. Osborn S. V., Hampton K. K., Smillie D., Channer K. S., Daly M. E. Platelet glycoprotein IIIa gene polymorphism and myocardial infarction. Lancet. 1996 Nov 9;348(9037):1309–1310. doi: 10.1016/s0140-6736(05)65785-6. [DOI] [PubMed] [Google Scholar]
  12. Ostergaard L., Møller J. K., Andersen B., Olesen F. Diagnosis of urogenital Chlamydia trachomatis infection in women based on mailed samples obtained at home: multipractice comparative study. BMJ. 1996 Nov 9;313(7066):1186–1189. doi: 10.1136/bmj.313.7066.1186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Paul I. D., Caul E. O. Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample. J Clin Microbiol. 1990 Feb;28(2):220–222. doi: 10.1128/jcm.28.2.220-222.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis Suppl. 1990;69:157–167. [PubMed] [Google Scholar]
  15. Robson J., Falshaw M. Audit of preventive activities in 16 inner London practices using a validated measure of patient population, the 'active patient' denominator. Healthy Eastenders Project. Br J Gen Pract. 1995 Sep;45(398):463–466. [PMC free article] [PubMed] [Google Scholar]
  16. Sanders J. W., Hook E. W., 3rd, Welsh L. E., Shepherd M. E., Quinn T. C. Evaluation of an enzyme immunoassay for detection of Chlamydia trachomatis in urine of asymptomatic men. J Clin Microbiol. 1994 Jan;32(1):24–27. doi: 10.1128/jcm.32.1.24-27.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Schachter J., Stamm W. E., Quinn T. C., Andrews W. W., Burczak J. D., Lee H. H. Ligase chain reaction to detect Chlamydia trachomatis infection of the cervix. J Clin Microbiol. 1994 Oct;32(10):2540–2543. doi: 10.1128/jcm.32.10.2540-2543.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Schachter J., Stamm W. E., Quinn T. C. Discrepant analysis and screening for Chlamydia trachomatis. Lancet. 1996 Nov 9;348(9037):1308–1309. doi: 10.1016/S0140-6736(05)65783-2. [DOI] [PubMed] [Google Scholar]
  19. Schepetiuk S., Kok T., Martin L., Waddell R., Higgins G. Detection of Chlamydia trachomatis in urine samples by nucleic acid tests: comparison with culture and enzyme immunoassay of genital swab specimens. J Clin Microbiol. 1997 Dec;35(12):3355–3357. doi: 10.1128/jcm.35.12.3355-3357.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scholes D., Stergachis A., Heidrich F. E., Andrilla H., Holmes K. K., Stamm W. E. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996 May 23;334(21):1362–1366. doi: 10.1056/NEJM199605233342103. [DOI] [PubMed] [Google Scholar]
  21. Stamm W. E. Expanding efforts to prevent chlamydial infection. N Engl J Med. 1998 Sep 10;339(11):768–770. doi: 10.1056/NEJM199809103391111. [DOI] [PubMed] [Google Scholar]
  22. Stary A. Chlamydia screening: which sample for which technique? Genitourin Med. 1997 Apr;73(2):99–102. doi: 10.1136/sti.73.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Stokes T. Screening for Chlamydia in general practice: a literature review and summary of the evidence. J Public Health Med. 1997 Jun;19(2):222–232. doi: 10.1093/oxfordjournals.pubmed.a024614. [DOI] [PubMed] [Google Scholar]
  24. Tabrizi S. N., Paterson B., Fairley C. K., Bowden F. J., Garland S. M. A self-administered technique for the detection of sexually transmitted diseases in remote communities. J Infect Dis. 1997 Jul;176(1):289–292. doi: 10.1086/517269. [DOI] [PubMed] [Google Scholar]
  25. Taylor-Robinson D. Chlamydia trachomatis and sexually transmitted disease. BMJ. 1994 Jan 15;308(6922):150–151. doi: 10.1136/bmj.308.6922.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. van der Graaf Y., Vooijs G. P. False negative rate in cervical cytology. J Clin Pathol. 1987 Apr;40(4):438–442. doi: 10.1136/jcp.40.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES